Rho/ROCK signaling and α-catenin mediate β-catenin–driven hyperplasia in the adrenal cortex via adherens junctions
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci196271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Mesut Berber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Adherens Junctions, beta Catenin, rho-Associated Kinases, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH, Swiss National Science Foundation.
Abstract (Originalsprache)
How β-catenin (βCat) mediates tissue hyperplasia is poorly understood. To explore this, we employed the adrenal cortex as a model system given its stereotypical spatial organization and the important role βCat plays in homeostasis and disease. For example, excessive production of aldosterone by the adrenal cortex (primary aldosteronism [PA]) is a major cause of cardiovascular morbidity and is associated with βCat gain of function (βCat-GOF). Adherens junctions (AJs) connect the actin cytoskeletons of adjacent zona glomerulosa (zG) cells via a cadherin–βCat–α-catenin complex and mediate aldosterone production. Whether βCat-GOF drives zG hyperplasia, a key feature of PA, via AJs is unknown. Here, we showed that aldosterone secretagogues (K + and AngII) and βCat-GOF mediated AJ formation via Rho/ROCK/actomyosin signaling. In addition, Rho/ROCK inhibition led to altered zG rosette morphology and decreased aldosterone production. Mice with zG-specific βCat-GOF demonstrated increased AJ formation and zG hyperplasia, which was blunted by Rho/ROCK inhibition and deletion of α-catenin (αCat). βCat also impacted AJ formation independently of its role as a transcription factor. Furthermore, analysis of human aldosterone-producing adenomas revealed high levels of βCat expression were associated with increased membranous expression of K-cadherin. Together, our findings identified Rho/ROCK signaling and αCat as key mediators of AJ formation and βCat-driven hyperplasia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
- Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität, Munich, Germany.
- The LOOP Zurich Medical Research Center, Zurich, Switzerland.
Förderung
- NIDDK NIH HHS
- NIH
- Swiss National Science Foundation
- American Heart Association
Zitieren
APA
Berber, M., Haykir, B., Guagliardo, N. A., Chortis, V., Borges, K. S., Barrett, P. Q., Beuschlein, F., Carlone, D. L., & Breault, D. T. (2026). Rho/ROCK signaling and α-catenin mediate β-catenin–driven hyperplasia in the adrenal cortex via adherens junctions. Journal of Clinical Investigation. https://doi.org/10.1172/jci196271
Vancouver
Berber M, Haykir B, Guagliardo NA, Chortis V, Borges KS, Barrett PQ, et al. Rho/ROCK signaling and α-catenin mediate β-catenin–driven hyperplasia in the adrenal cortex via adherens junctions. Journal of Clinical Investigation. 2026. doi:10.1172/jci196271
BibTeX
@article{Berber2026,
author = {Berber, Mesut and Haykir, Betul and Guagliardo, Nick A and Chortis, Vasileios and Borges, Kleiton Silva and Barrett, Paula Q and Beuschlein, Felix and Carlone, Diana L and Breault, David T},
title = {Rho/ROCK signaling and α-catenin mediate β-catenin–driven hyperplasia in the adrenal cortex via adherens junctions},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci196271}
}
EUVIMED